Monthly Archives: December 2018


New Hope for Macular Degeneration The study was monitored by world renowned endocrine specialist and melatonin expert Walter Pierpaoli MD, PhD. who was also responsible for the refinement of the bonded melatonin formulation used in the trial. DR. Walter Pierpaoli is director of the Jean Choay Institute for Biomedicals Research, Switzerland and President of the […]


Within 6 months 90% of the trial participants had improved their AMD condition. The improvements continued until the trial ended at 24 months. Clinical Publication Figure 1 – – Before and after fundus pics were taken of all trial participants. Complete Study Overview Figure 1: The left slide shows the eye of a 67 year […]


 New Breakthrough for Age-Related Macular Degeneration ARMeD™ Advanced Retinal Support formula is based on published research conducted by Changxian Yi et al, – titled “Effects of melatonin in age-related macular degeneration”, Ann NY Acad Sci, 1057:384-392,2005 with assistance from the world renowned endrocrin specialist Dr. Walter Pierpaoli.  The ARMeD™ formula contains a unique melatonin from […]


Q. Are Can-C™ Eye Drops Really safe for animals? A: Yes, N-Acetylcarnosine (Can-C™) eye drops have been researched in humans and in animals for over ten years and used for more than five years by thousands in Russia, China, Europe and the US without any side effects or complications. In fact the antioxidant properties of […]


Animal Clinical Trials  Clinical Study Proves Can-C™ Safe and Effective “A new phenomenon of “melting snow” in only a few short weeks… The testing of various anti-glycation agents over nearly a decade led a Russian research team to the development of n-alpha-acetylcarnosine as a delivery system for the natural eye anti-oxidant of L-carnosine. Once laboratory […]


“The clinical research  of age-related cataracts in canines and rabbits has been conducted and the efficacy of using N-acetylcarnosine for cataract treatment was established. The striking results in canines and rabbits for both cataract reversal and prevention of lens opacities are clear.” Dr. Mark Babizhayev MA, PhDSenior Research Investigator – Innovative Vision Products Many dog […]


A New Breakthrough from, Innovative Vision Products Inc. Can-C Plus Tablets, now available in US and European Markets: Patents: (WO 2004/028536 A1; WO 94/19325; WO 95/12581; WO 2004/064866 A1) Synergism of histidyl dipeptides and amino acids proven to be benefical in ophthalmic treatments. With the knowledge that there is a natural range of the histidyl […]


[facts serving=”3 Capsules” container=”30″ ingredients=”Micro-crystalline Cellulose Phosphate, Di Basic Calcium Phosphate, Magnesium Sterate, Cross Povidone, Aerosil, Starch” info=” Note: Keep out of reach of children. Not for use by pregnant or lactating women.The above information is the translation of the manufacturer’s insert. It is provided under the supplying company’s terms and conditions and should not […]


Introducing Can-C Plus™ A Wise Choice for your Eyes Dr. Mark Babizhayev, a leading biophysicist in the area of natural peptides and their unique ability to reverse oxidation has developed and patented this specific oral formulation to effectively sustain the activity of Can-C eye drops for longer periods within the eye tissues. When taken consistently […]


This unique “IVP” N-acetylcarnosine (Can-C™) formula with synergistic lubricants shows beneficial results for the following eye-disorders Glaucoma Contact lens disorders. Presbyopia Corneal disorders. Chronic eyestrain. Computer vision syndrome. Ocular inflammation. Blurred vision. Dry eye syndrome. Retinal disease Vitreous opacities and lesions. Click to hear an interview on Can-C and eye disorders Not only do the […]